<DOC>
	<DOCNO>NCT00334061</DOCNO>
	<brief_summary>This clinical evaluation prospective , single-arm , multi-center trial . The purpose clinical evaluation ass safety effectiveness Penumbra System revascularization patient present acute ischemic stroke secondary intracranial , large vessel , occlusive disease .</brief_summary>
	<brief_title>Study Assess Safety Effectiveness Penumbra System</brief_title>
	<detailed_description>Purpose : The purpose clinical evaluation ass safety effectiveness Penumbra System revascularization patient present acute ischemic stroke secondary intracranial , large vessel , occlusive disease . Up 125 evaluable patient enrol study .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>Clinical sign consistent acute ischemic stroke 18 79 year age Neurological deficit result NIH Stroke Scale ( NIHSS ) score &gt; 8 TIMI 0 TIMI I flow vessel accessible Penumbra System Signed informed consent Present within 8 hour stroke symptom onset ; ineligible refractory intravenous tissue plasminogen activator ( tPA ) therapy present within 3 hour symptom onset . Evidence rapidly improve neurological sign stroke time enrollment NIHSS &gt; 30 coma Females pregnant Vessel tortuosity difficult allow endovascular access Known hemorrhagic diathesis , coagulation deficiency , oral anticoagulant therapy International Normalized Ratio ( INR ) &gt; 3.0 Partial thromboplastin time ( PTT ) great 2 time lab normal Admission platelet &lt; 30,000 Preexisting neurological psychiatric disease could confound study result Known severe allergy contrast medium Uncontrolled hypertension Computed tomography ( CT ) evidence significant mass effect midline shift CT reveal evidence large hypodensity region &gt; 1/3 middle cerebral artery territory CT reveal evidence intracranial hemorrhage CT reveal significant mass effect midline shift Angiographic evidence arterial stenosis proximal occlusion could prevent thrombus removal Angiographic evidence preexist arterial injury Life expectancy le 90 day Participation another clinical investigation could confound evaluation study device .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Penumbra</keyword>
	<keyword>Ischemic</keyword>
	<keyword>Stroke</keyword>
	<keyword>Intervention</keyword>
	<keyword>Neurovascular</keyword>
	<keyword>Thrombus</keyword>
	<keyword>Embolectomy</keyword>
	<keyword>Ischemic stroke</keyword>
</DOC>